Institutional Ownership Relay Therapeutics, Inc. (RLAY)
This table provides information about the institutional ownership of Relay Therapeutics, Inc. (RLAY). We have compiled data on the 213 institutions that hold shares in the stock, with a total of 172 Million shares, which have been reported (via 13F filing form) to have a value of $578 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sb Investment Advisers (Uk) LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
27,904,963
shares
|
$93.5 Million
0.77% of portfolio
|
Q3 2020
New holding
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
13,445,704
shares
|
$45 Million
0.1% of portfolio
|
Q2 2025
Added 24.19%
|
|
Commodore Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
13,350,000
shares
|
$44.7 Million
4.31% of portfolio
|
Q2 2025
New holding
|
|
Casdin Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
11,398,574
shares
|
$38.2 Million
5.53% of portfolio
|
Q2 2025
Added 25.28%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,542,667
shares
|
$35.3 Million
0.0% of portfolio
|
Q2 2024
Added 7.62%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
9,379,851
shares
|
$31.4 Million
0.0% of portfolio
|
Q2 2025
Reduced 22.52%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Aug 14, 2025 Q2 2025 |
8,230,870
shares
|
$27.6 Million
0.65% of portfolio
|
Q2 2025
Added 11.57%
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
8,068,058
shares
|
$27 Million
1.67% of portfolio
|
Q4 2024
Added 126.12%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
5,202,791
shares
|
$17.4 Million
0.0% of portfolio
|
Q2 2025
Added 0.85%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
4,909,771
shares
|
$16.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.38%
|
|
Nextech Invest, Ltd.
Zurich, V8 |
Aug 14, 2025 Q2 2025 |
3,846,409
shares
|
$12.9 Million
2.52% of portfolio
|
Q1 2025
New holding
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
3,846,409
shares
|
$12.9 Million
2.95% of portfolio
|
Q1 2024
Added 185.68%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
3,229,666
shares
|
$10.8 Million
0.0% of portfolio
|
Q2 2025
Added 5.2%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
2,887,014
shares
|
$9.67 Million
1.19% of portfolio
|
Q2 2025
Reduced 5.75%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,875,936
shares
|
$9.63 Million
0.0% of portfolio
|
Q2 2025
Reduced 17.31%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
2,789,460
shares
|
$9.34 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.34%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
2,282,680
shares
|
$7.65 Million
1.55% of portfolio
|
Q2 2025
Reduced 0.58%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,935,167
shares
|
$6.48 Million
0.0% of portfolio
|
Q2 2025
Reduced 6.87%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,870,362
shares
|
$6.27 Million
0.0% of portfolio
|
Q2 2025
Reduced 36.44%
|
|
Alphabet Inc.
Mountain View, CA |
Jul 31, 2025 Q2 2025 |
1,568,753
shares
|
$5.26 Million
0.35% of portfolio
|
Q1 2022
Added 0.29%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,508,210
shares
|
$5.05 Million
0.01% of portfolio
|
Q2 2025
Reduced 33.74%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,422,346
shares
|
$4.76 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.72%
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,320,130
shares
|
$4.42 Million
0.0% of portfolio
|
Q2 2025
Added 138.11%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
1,162,092
shares
|
$3.89 Million
0.0% of portfolio
|
Q2 2025
Added 1.68%
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,160,117
shares
|
$3.89 Million
0.04% of portfolio
|
Q2 2023
Added 308.49%
|